Patient-centered Communication About Healthy Weight in Early Breast Cancer
NCT ID: NCT04504201
Last Updated: 2022-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2020-06-15
2020-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer
NCT02037542
The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors
NCT02030353
Rural Women Connecting for Better Health
NCT01441011
Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors
NCT04753268
Weight Management Among Breast Cancer Survivors
NCT02387671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Objective:
1. Understand patient-centered perspectives on health weight communication with oncology clinicians by conducting focus groups
Secondary Objective
2. Understand oncology clinician perspectives on patient center communications for healthy weight interactions through semi-structured interviews.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Breast Cancer Patients
Early breast cancer patients (Stage I-III) who have completed primary treatment with a current Body mass index (BMI) over 30.
Focus Group
Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.
Medical Oncology Clinicians
Oncology providers associated with community-based practices
Focus Group
Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus Group
Breast cancer patients and oncology clinicians will participate in separate focus groups discussing patient-centered communication about healthy weight.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with early breast cancer, Stages I-III
* Completed primary treatment (Surgery, chemotherapy, radiation) within past 2 years
* Body mass Index of equal or greater than 30
* Breast cancer oncology provider in North Carolina with MD/DO/PA/NP/RN
* associated with community-based practices
Exclusion Criteria
21 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Cancer Society, Inc.
OTHER
Pfizer
INDUSTRY
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirsten Nyrop, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LCCC 1954
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.